This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (75)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Diane L. Schneider, MD, MSc; Elizabeth L. Barrett-Connor, MD

Arch Intern Med. 1997;157(11):1241-1245.

Abstract
Background
The level of urinary, type I collagen, crosslinked N-telopeptides (NTX) is a new marker of bone resorption. To our knowledge, no population-based studies of older adults have determined whether this measure can identify individuals with osteoporosis.

Objectives
To measure the levels of NTX in a crosssectional study of ambulatory, older, white adults and to evaluate whether this measure of bone resorption could identify individuals with osteoporosis.

Patients and Methods
The subjects, aged 50 to 98 years, formed 3 groups: 374 men, 223 women currently using estrogen, and 364 women not currently using estrogen. A standard medical history and validated record of medication use were obtained. Height and weight were measured. Bone mineral density (BMD) was measured at the hip and lumbar spine using dual energy x-ray absorptiometry. The levels of NTX were measured by enzyme-linked immunosorbent assay.

Results
Overall, the levels of NTX increased slightly with age in men and in estrogen users and more dramatically in nonestrogen users. In a model adjusted for all major risk factors for osteoporosis, there was a significant decrease in BMD levels by increasing quintiles of NTX levels at the hip and spine in women with and without estrogen use and at the hip in men. Using sexspecific, peak bone mass criteria and age-adjusted analyses, the levels of NTX discriminated between normal (—1.0 SD), osteopenic (>—1.0 and <-2.5 SD), and osteoporotic (—2.5 SD) BMD levels in all groups except the spine in men.

Conclusions
The levels of NTX uniquely discriminated between older adults with normal, osteopenic, or osteoporotic BMD levels. If confirmed, these data suggest that NTX levels could be used to predict current osteoporosis in older men and women.

Arch Intern Med. 1997;157:1241-1245

Author Affiliations
From the University of California, San Diego, La Jolla.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Using biochemical markers of bone turnover in clinical practice
SINGER and EYRE
Cleveland Clinic Journal of Medicine 2008;75:739-750.
ABSTRACT | FULL TEXT  

High bone turnover is associated with accelerated bone loss but not with increased fracture risk in men aged 50 and over: the prospective MINOS study
Szulc et al.
Ann Rheum Dis 2008;67:1249-1255.
ABSTRACT | FULL TEXT  

Bone Density and Bone-Related Biochemical Variables in Normal Men: A Longitudinal Study
Scopacasa et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2002;57:M385-391.
ABSTRACT | FULL TEXT  

Nitrogen Metabolism and Bone Metabolism Markers in Healthy Adults during 16 Weeks of Bed Rest
Scheld et al.
Clin. Chem. 2001;47:1688-1695.
ABSTRACT | FULL TEXT  

Biochemical Response to Treatment of Bone Hyperresorption in Chronically Critically Ill Patients
Nierman and Mechanick
Chest 2000;118:761-766.
ABSTRACT | FULL TEXT  

Chronic Glucocorticoid Therapy-Induced Osteoporosis in Patients With Obstructive Lung Disease*
Goldstein et al.
Chest 1999;116:1733-1749.
ABSTRACT | FULL TEXT  

Clinical Utility of Biochemical Markers of Bone Remodeling
Watts
Clin. Chem. 1999;45:1359-1368.
ABSTRACT | FULL TEXT  

Collagen N-Telopeptide Excretion in Men: The Effects of Age and Intrasubject Variability
Orwoll et al.
J. Clin. Endocrinol. Metab. 1998;83:3930-3935.
ABSTRACT | FULL TEXT  

Body Weight Predicts Bone Density Better Than Resorption Markers
Mazess
Arch Intern Med 1998;158:298-300.
FULL TEXT